Related Experiment Videos
Heteromeric association creates a P2Y-like adenosine receptor
K Yoshioka1, O Saitoh, H Nakata
1Department of Molecular and Cellular Neurobiology, Tokyo Metropolitan Institute for Neuroscience, Fuchu, Tokyo 183-8526, Japan.
Summary
The A1 adenosine receptor (A1R) and P2Y1 receptor (P2Y1R) can form functional heteromers. This receptor association alters purinergic signaling, suggesting new ways to control cellular functions.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Adenosine and ATP are key components of the purinergic system, modulating cellular functions via P1 and P2 receptors.
- While adenosine generally inhibits and ATP excites the central nervous system, the formation of heteromers between P1 and P2 receptors remains largely unexplored.
Purpose of the Study:
- To investigate the potential for oligomeric association between distinct G protein-coupled P1 and P2 receptors.
- To determine if such associations form functional heteromers and alter purinergic signaling.
Main Methods:
- Co-immunoprecipitation assays in HEK293T cells to detect receptor association.
- Radioligand binding assays to assess agonist and antagonist interactions.
- Forskolin-stimulated cAMP accumulation assays to evaluate functional consequences.
- Double immunofluorescence and confocal microscopy for receptor colocalization.
Main Results:
- A1 adenosine receptor (A1R) and P2Y1 receptor (P2Y1R) coimmunoprecipitated, indicating oligomeric association.
- Coexpression of A1R and P2Y1R altered agonist/antagonist binding affinities and introduced P2Y1R agonist activity at A1R.
- ADPbetaS binding to coexpressed cells inhibited cAMP accumulation via Gi/o proteins, mimicking A1R activity.
- High colocalization of A1R and P2Y1R was observed in cotransfected cells.
Conclusions:
- A1R and P2Y1R can form functional heteromers, suggesting a novel mechanism for purinergic signaling diversity.
- This heteromerization generates A1R with P2Y1R-like agonistic pharmacology.
- The findings provide a molecular basis for expanded control over complex purinergic cascades.